Get 20% lifetime commission for referring investors to digrin.com
here.
MiNK Therapeutics, Inc. ( INKT) - Stock Earnings
INKT Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
INKT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.6 million USD | — USD |
| 2026Q1 | -2.7 million USD | — USD |
| 2026Q2 | -3.1 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INKT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.5 million USD | — USD |
| 2024 | -10.8 million USD | — USD |
| 2025 | -12.5 million USD | — USD |
| 2026 Est. | — | — |
INKT
Price: $9.41
52 week price:
Earnings Per Share: -2.37 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4128
Market Capitalization: 59.3 million